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In recent years, the potential of nanowires for applications within nanomedicine, including drug delivery and
diagnostics, have been explored by several groups. The small diameter of nanowires allows them to cross
the lipid bilayer of the cell membrane without causing signiﬁcant damage, which makes them attractive as a
tool for gaining access to the intracellular environment. Recent studies report on an approach using vertically
aligned nanowires ﬁxed to a surface instead of nanowires in solution. Nanowire arrays hold promise of simpler
maneuvering and additional applications within drug delivery, biosensing, and electrophysiology in living cells,
all of which are explored in this paper.
Keywords: Nanowires, Drug Delivery, Biosensor, Electrophysiology, Nanoelectrode, Nanorod, Nanoﬁber,
Nanomedicine.
INTRODUCTION
The emerging ﬁeld of nanomedicine has been propelled by the
growth and gradual overlap of disciplines such as nanotechno-
logy, biochemistry, pharmacology, and medicine, all of which
are themselves highly interdisciplinary. The new ﬁeld of nano-
medicine integrates advanced nanomaterials such as nanowire
(NW) arrays with biomolecules, cells, and eventually organisms,
in order to develop novel platforms for applications such as
biosensing, drug screening, and drug delivery.
In biochemistry, developments in genomics and proteomics
have helped elucidate the molecular basis of many diseases. They
have generated knowledge about disease biomarkers, with poten-
tial for personalized medicine in diagnostics, in which ﬁne ther-
apies (drug type, dose) can be adapted to each patient, reducing
side effects and improving drug efﬁciency.
Drug discovery has also beneﬁted from these developments
with the design of new drugs and the development of high-
throughput screening (HTS) strategies for new molecules. Com-
bined with drug delivery strategies based on novel nanomaterials,
with better biocompatibility and target speciﬁcity, nanomedicine
opens the way to a myriad of potential new therapies (Cheng
et al., 2006).
Based on these developments, there are three main impact
areas foreseen for nanomedicine:
(1) high-quality and fast diagnosis of diseases, with the devel-
opment of biosensors;
(2) drug discovery, with the development of fast and cheap
screening strategies of potential new drugs; and
(3) drug delivery, with targeted delivery and translocation of
active therapeutic reagents.
Neuroscience raises additional challenges that can also beneﬁt
from the development of novel nanotechnology-based platforms.
∗Author to whom correspondence should be addressed.
These challenges stem in particular from the regulation of the
brain microenvironment through the blood-brain barrier and the
organization of neurons and their speciﬁc response to a panel of
neurotransmitters.
The use of carbon nanotubes (CNTs) for the delivery of ther-
apeutic agents has recently been demonstrated, with applications
for the delivery of genes or vaccines, and with potential for
higher-efﬁciency release of molecules used in cancer and AIDS
therapies (Lacerda et al., 2007). Recently, a couple of laboratories
(Hällström et al., 2007; Kim et al., 2007) reported on an alter-
native method of interfacing NWs and cells that holds promise
of simpler maneuvering and additional applications. Instead of
working with solutions of NWs, suspensions of living cells are
added to an array of vertically aligned NWs that are ﬁxed to a
surface. Like CNTs, the NW arrays present a major potential in
nanomedicine, with possible applications for drug delivery and
discovery. In addition, these arrays could provide a huge potential
for diagnostics in living cells.
Nanowires—Structures and Properties of
Relevance for Biological Applications
NWs are solid, crystalline rods with diameters in the nanometer
range (10–100 nm) and typical lengths of around a few micro-
meters. These objects can be made from a wide range of
inorganic materials (Lu et al., 2006; Wu et al., 2002) and
are occasionally termed nanorods or nanowhiskers. In con-
trast, CNTs are hollow, cylindrical molecules made purely from
carbon.
The growth of linear crystals is promoted by the presence
of nanoscale metal catalyst particles on a surface. At elevated
temperatures the catalyst particles act as ultraﬁne melting pots,
consisting of the molten metal particle and semiconductor atoms
supplied from a dilute gas in the growth chamber. When this alloy
is saturated, a ﬁne crystalline wire grows out from the particle
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(a)
(b)
Fig. 1. (a) Growth model for NWs. Gold (Au) catalyst nanoparticles are
deposited on a surface. At elevated temperatures, atoms from the sur-
rounding gas (in this example, indium [In] and arsenic [As]) assemble
into a linear crystal underneath each catalyst particle. (b) Scanning elec-
tron micrograph of an aligned NW array of indium-arsenide (InAs), scale
bar 1 m. Inset shows a zoom on a single NW with the gold parti-
cle remaining at the top, scale bar 100 nm. (Courtesy of M. Aagesen,
University of Copenhagen.)
and lifts it from the surface (Fig. 1(a)). This growth procedure
results in a surface covered with a forest of vertically aligned
NWs. The diameter of a wire is determined by the size of catalyst
particle; wires with narrow diameter distributions can be grown
through proper preparation of the catalyst.
The density and positions of NWs on the surface is determined
by the initial distribution of the catalyst particles. In Figure 1(b)
catalyst particles were deposited randomly on the surface prior to
growth, resulting in a disordered pattern. However, it is possible
to predeﬁne exactly the positions of the NWs by arranging the
catalyst particles in any desired pattern prior to growth using
lithographic methods. (Mårtensson, 2004). Ordered arrays can
also be made from CNTs and nanoﬁbers and are commercially
available.
Usually NWs are harvested from the surface after growth and
used in solution or deposited onto a new surface. However, the
focus of the present paper is to explore the applications of NWs
that have been left standing on the surface (from here on referred
to as NW arrays). An example of such a NW array is shown in
Figure 1(b).
Under well-controlled conditions, large areas of wires with
uniform properties, in both their physical dimensions and their
intrinsic properties (crystal structure, electrical and optical prop-
erties) (Li et al., 2006; Lu et al., 2006; Thelander et al., 2006)
can be grown. The latter is given solely by their elemen-
tal composition; i.e., wires made from semiconductor materials
like silicon and germanium (group IV elements) or gallium-
arsenide and indium-phosphide (group III–V) will indeed be
semiconducting. CNTs can possess different electrical properties,
depending on their microscopic geometry, and thus an ensem-
ble of nanotubes will contain a random distribution of metallic
and semiconducting tubes. For applications based on their elec-
trical properties this is a nuisance, but structurally it makes no
signiﬁcant difference.
In addition to their natural properties and geometry that make
them attractive for biological applications, semiconductor NWs
can be ﬁnely tailored, which opens a large number of options in
their application to biological material: They can be doped with
minute concentrations of other elements, whereby their conduc-
tivity can be adjusted, in contrast to metallic wires. In addition,
their elemental composition can be changed along the wire dur-
ing growth, forming so-called heterostructures (Lauhon et al.,
2004). This opens possibilities for functionalizing various parts
of the NWs selectively according to a design deﬁned during
growth. Finally, the surface of NWs can be customized with coat-
ings of protective or active layers, either by making core–shell
structures directly during growth or by post-treatments. Most
importantly, their surfaces can be chemically modiﬁed, allowing
a wide range of functionalizations (Patolsky et al., 2006).
The interest in semiconductor NWs was initially not for bio-
logical applications, but mainly due to their favorable elec-
tronic and optical properties. For instance, high-performance
nanoscale transistors (ﬁeld-effect transistors, or FETs) can be
made from semiconductor NWs (NW-FETs), making it plau-
sible that nanoscale electronic circuits can be based on these
wires (Li et al., 2006; Thelander et al., 2006). In the context of
nanomedicine is it interesting to note that ultrasensitive biosen-
sors can be made from NW-FETs by properly functionalizing
their surface (Patolsky et al., 2006). Such sensors have direct
electrical readout and offer label-free detection, as also demon-
strated for CNT-based biosensors (Kumar, 2007). Recent pub-
lications also demonstrate the potential of arrays of NWs for
applications in living cells, which is the scope of this paper.
Why are NW Arrays Attractive for
Applications with Living Cells?
The most apparent motivation for looking at applications of NWs
in nanomedicine is that their dimensions are compatible with
the dimensions of mammalian cells, with membrane thickness of
4–5 nm and diameters between 1 and 20 m. The small diameter
of the NWs allows them to cross the lipid bilayer of the cell mem-
brane without causing signiﬁcant damage (Lacerda et al., 2007).
By comparison, micropipettes commonly used as microinjectors
or for electrophysiology measurements on cells have a diame-
ter of about 1 m, which is up to 100 times larger, so based
on geometry NWs are potentially less invasive than existing
tools.
At the same time, the height of the wires can be adjusted for
the purpose of adapting the array to cell types of different dimen-
sions or for bringing different parts of cells within reach. NWs
of less than 1 m would cross the cell membrane and reach
into the cytosol close to the membrane, whereas longer wires of
several micrometers could possibly penetrate into the cell nucleus
or other compartments. Wires could even be long enough to enter
a cell on one side and exit on the other.
The expected limited invasiveness of the NWs due to their
dimensions is not their only advantage. There are also a number of
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important advantages stemming from the fact that they are grown
on surfaces with controlled distribution and orientation. First of
all, it is possible to control the position of the NWs via pho-
tolithography. This allows organization of the NWs into arrays of
various designs. Moreover, NW density can be controlled, and this
allows for tuning the roughness of the surface, and most impor-
tantly, the number of NWs to be inserted into each cell.
In the last few years there has been considerable progress in
the design of vertically aligned NWs for the purpose of interfac-
ing them with cells, primarily represented by the work done by
McKnight et al. (Guillorn et al., 2002; McKnight, Melechko et al.,
2006; McKnight, Peeraphatdit et al., 2006). As an example, the
NW array can be marked with an indexed grid, which facilitates
tracking of speciﬁc positions in the array, making it possible to
record time series of speciﬁc cells (McKnight et al., 2004).
For the reasons mentioned earlier, it should be possible to
create a platform with an ideal design; i.e., a customized array
of vertically aligned NWs, with deﬁned orientation, length, and
diameter, providing a support with controlled surface roughness,
which is a crucial parameter for cell adhesion, and with a prede-
ﬁned number of probes per cell.
Arrays of Nanowires Incorporated in Living Cells
The ﬁrst evidence that it is possible to interface living cells with
an array of vertically aligned nanostructures was given in 2003 by
McKnight et al. Here an array of conically shaped carbon nano-
structures with tip diameters in the range of 30 nm and lengths
of 7 m were functionalized with plasmid DNA encoding green
ﬂuorescent protein (GFP). Chinese hamster ovary (CHO) cells
were forced onto this array by centrifugation and by subsequently
applying pressure. Scanning electron micrographs revealed that
the CHO cells were penetrated by the nanostructures, but only a
transfection efﬁciency of less than 1% was achieved. Despite the
penetrating structures and the violent treatment of the cells, the
cells survived and proliferated for several days, indicating that
the penetrating wires did not undermine the cell integrity.
A different approach was presented in the recent publications
of Kim et al. (2007) and Hällström et al. (2007), in which NWs
ﬁxed to a surface penetrate cells without the use of an external
force.
Kim et al. cultured human embryonic kidney (HEK293) cells
and mouse embryonic stem (mES) cells directly on an array of
silicon NWs. One hour after deposition of cell suspension the
wires were shown to penetrate the cells. The viability was seen
to increase with decreasing diameter of the NWs, consistent with
the intuition that a smaller diameter will create less stress when
penetrating the lipid bilayer.
Similar observations were made by Hällström et al. on mouse
neurons cultured on a surface of vertically aligned gallium-
phosphide (GaP) NWs. The neurons had an even better adherence
and a higher viability on a GaP-NW surface compared to a pla-
nar GaP surface. Although it is surprising that cells should have
higher viability on a surface of nanoneedles, it could be an indi-
cation that the roughness of the nanostructured surface improves
the adherence and thereby the viability, as seen for some other
mammalian cell types (Khang et al., 2007; Kunzler et al., 2007).
In addition, we recently observed the incorporation of non-
homogeneous arrays (diameter 70–270 nm) of indium-arsenide
(InAs) NWs in HEK293 cells as illustrated in Figure 2, without
alteration of the cell integrity (Berthing, unpublished).
Fig. 2. (Left) Scanning electron micrograph of HEK293 cell cultured on
an InAs NW array, scale bar 10 m. Insert is a zoom on the NW array,
scale bar 1 m. (Right) InAs NWs embedded in HEK293 cell membrane,
scale bar 1 m.
This new approach seems attractive because of the simple pro-
tocol of using the NW array as a cell culture surface, but it might
be a problem to apply it to more sensitive cell lines that have
speciﬁc requirements to the culturing conditions. As an alterna-
tive, it would be interesting to be able to insert a NW array in
a population of cells cultured on standard cell culture dishes or
even in cells in tissue samples.
The mechanism of cell penetration by the wires is not yet
known. Possible mechanisms could be a mechanical penetration
occurring simply when the cells are settling onto the surface,
or an active internalization through endocytosis. In the studies
by Kim et al. and Hällström et al. it was observed that NWs
in contact with cells were bent, which indicates that the cells
exert a force on the NWs. This could possibly be due to an
interaction between the wires and the cytoskeleton and might
support the hypothesis of an active uptake of the wires by the
cellular machinery. Taking advantage of cellular mechanics for
the uptake of NWs is preferable for future applications of NW
arrays because it most likely is less invasive, and it excludes the
need of applying an external force.
The potential for widespread applications of NWs as intracel-
lular probes is indicated by the various cell types that have been
shown to be viable for several days when penetrated by NWs of
different materials and geometry (Table 1). The cell types that
have been tested span a range of important classes like epithelial
cells, neurons, embryonic cells, and cancer cells, suggesting that
the applications discussed in this text can be adapted to a vari-
ety of cell types and eventually tissues. Remarkably, even non-
adherent cell lines can be interfaced with a NW array (McKnight
et al., 2004).
The longest survival time of cells cultured on a NW surface is
reported by McKnight et al. (2004), in which CHO cells survive
more than three weeks on a silicon surface with vertically aligned
carbon NWs (Table 1). These observations show the potential of
arrays of NWs for long-term investigations of cells, which is a
crucial parameter for the design of future applications.
There have been numerous investigations of the cytotoxicity of
NWs and nanotubes in solution that have been taken up by cells
(Cai et al., 2007). Oxidative stress (Manna et al., 2005), reduced
respiratory activity (Jia et al., 2005), and enzyme inhibition (Yi
et al., 2007) are some of the risks mentioned, but the cytotoxic
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Table 1. Overview of the wide range of cell types that have been interfaced with NW arrays.
NW properties
Cell types Material Diameter (nm) Length (m) Min. viability (days) Ref.
HEK293 InAs 70–270 1–3 1 (Berthing, unpublished)
Si 90 3–6 1 (Kim, 2007)
mES Si 30–400 3–6 5–1 (Kim, 2007)
Mouse nerve cells GaP 50 2.5 3 (Hällström, 2007)
CHO CNF 100–200 10 22 (McKnight, 2003, 2004)
Mouse myeloma cells (non-adherent) CNF 100–200 10 3 (McKnight, 2004)
Rat pheochromocytoma neurons CNF 100–200 10 6 (McKnight, Melechko, 2006)
Rat hippocampal neurons CNF 100–200 10 6 (McKnight, Melechko, 2006)
HeLa∗ CNT 45 — 1 (Chen, 2007)
∗This study was not done on an array, but with a single CNT. It is included because it showed that cancer cells can be penetrated by CNTs. Length of CNT was not reported.
effects change with the dimensions and materials of the NWs (Jia
et al., 2005) and are different for each cell type, so additional
investigation need to be done in this ﬁeld. It is also plausible
that the toxic effects will be different when the wires are ﬁxed
to a surface, because there is not the same risk of formation of
cytotoxic aggregates or accumulations of wires in intracellular
compartments (Lacerda et al., 2007).
So far the viability of cells penetrated by ﬁxed NWs has been
evaluated based on rate of proliferation, membrane integrity, and
respiratory activity. The membrane integrity (Hällström et al.,
2007; Kim et al., 2007) and respiratory activity (Hällström et al.,
2007) does not seem to be affected, but it is indicated that prolif-
eration of mouse myeloma cells is slowed down upon interaction
with carbon nanoﬁbers (McKnight et al., 2004). Besides these
simple viability tests, the effects of penetrating the intracellular
environment are unknown. Before the potential of this platform
can be fully exploited, it is necessary to determine the conse-
quences of penetrating the cell membrane. For example, it will
be important to investigate whether the NWs disturb the intracel-
lular signaling pathways. Despite the outcome of future studies
on NW toxicity it will be a substantial improvement if it is pos-
sible to remove the wires after they have fulﬁlled their purpose.
This could be signiﬁcantly simpliﬁed by using NWs ﬁxed to a
surface instead of NWs in solution.
Acknowledging that NW toxicity is still under investigation,
but that initial studies show several cell types to be compatible
with arrays of NWs of different materials, the possible applica-
tions of such a device will be discussed next.
Delivery Platform for DNA, Particles, and Drugs
Current therapies are limited not only by the identiﬁcation of
efﬁcient potential therapeutic agents, but also by their inefﬁ-
cient translocation into the targeted cells. Indeed, because of
the lipophilic nature of biological membranes, many biologically
active compounds of different sizes need to be delivered inside
the cell or even to the nucleus, to exert therapeutic action. Using
arrays of NWs incorporated in cells with a controlled density
and location, delivery of various types of molecules in the cell
becomes possible (Fig. 3). A few examples of this application
in vitro appeared recently (Chen et al., 2007; Kim et al., 2007)
and clearly show the feasibility of using functionalized NWs for
the release of compounds in cells.
The ﬁrst applications of NW arrays concern DNA delivery.
As shown by Kim et al., it was possible to coat arrays of silicon
NWs with DNA encoding GFP and use its ﬂuorescence to esti-
mate the efﬁciency of DNA transfection (2007). The protein was
correctly expressed in the cells, indicating that the DNA was
transferred from the wires to the nucleus. The limited transfection
efﬁciency bserved can most probably be improved by deliver-
ing the DNA directly in the nucleus and increase the quantity of
DNA delivered to the cell. This is likely to be achievable because
it has already been shown that it is possible to penetrate the
nuclear envelope with a nanoneedle maneuvered by an atomic
force microscope (AFM) (Obataya et al., 2005). An advantage
of using a NW array as a delivery platform compared to, for
example, nanoparticles in solution is that the array provides spa-
tial control of the delivery. This could be used, for example, for
parallel delivery of several DNA constructs, while keeping track
of which population of cells received what type of DNA.
The size of a DNA molecule being quite considerable, translo-
cation of smaller sized molecules or particles, including proteins
such as antibodies, can easily be predicted. Such application has
not yet been demonstrated on arrays of NW, but the chemical
functionalization of NWs with various chemical groups and pro-
teins, including antibodies, is already possible (Liu, unpublished;
Patolsky et al., 2006; Stern et al., 2007).
Fig. 3. Present and future applications of NW arrays interfaced with liv-
ing cells: Delivery platform. Cell on a NW array illustrating the potential
as delivery and detection platform for DNA (blue), particles (red, yel-
low) and proteins (green). NWs have small enough dimensions to enable
direct delivery into the nucleus.
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When compounds are speciﬁcally immobilized on NWs, sim-
ple procedures to release the compounds in a cell can be used,
as illustrated by Chen et al. They were able to deliver particles
of 15 nm diameters into a cell using a CNT ﬁxed to an AFM
tip. The particles were connected to the CNT through disulﬁde
bridges that were automatically cleaved in the reducing cytosol
of the cell. A rewarding progress in this context would be the
development of other speciﬁc cleavage modes for the release of
compounds on demand.
The broad panel of compounds that can be attached to NWs
(nanoparticles, DNA, and proteins such as antibodies) suggests a
range of potential applications for diagnostic and drug discovery
in cell cultures. In the future, this approach is also promising for
the elaboration of novel therapies if detailed investigations reveal
a poor toxicity of various types of NW arrays.
The delivery of compounds of different sizes and compositions
at various locations in the cell using arrays of NWs has a high
potential for the delivery of poorly permeable compounds, or for
the delivery of compounds targeting speciﬁc cellular locations,
such as nuclear receptors. This type of targeted delivery will con-
siderably increase the efﬁciency of the compounds compared to
current therapies using the same molecules (Gupta t al., 2005).
As an example, peptides and antibodies are very high-potential
cancer drugs that are easily degraded in the body before reaching
the tumor cells. Using NW arrays after surgery to deliver these
compounds into the remaining tumor cells will increase their
efﬁciency but also contribute to a reduction of the side effects
observed today due to their administration in large quantities and
their toxic effect for healthy organs and tissues (Ferrari, 2005;
Torchilin et al., 2003).
An additional interesting potential for arrays of NWs consists
of the extraction of compounds from the cell. Such an approach
would require not only a noninvasive incorporation of the NWs
in the cell, but also a noninvasive extraction of the NWs. If suc-
cessful, it would open signiﬁcant prospective uses for diagnostics
on biopsies.
Arrays of NWs: A Biosensing Platform in
Living Cells
In the past decade, CNTs and NW-FETs have been developed
into very sensitive label-free biosensors for applications in vitro
(Cui et al., 2001; Patolsky et al., 2006). They were also recently
shown to be used to sense cellular events (Patolsky et al., 2006;
Stern et al., 2007) through modiﬁcation of extracellular solutions.
Therefore, NWs have already shown their potential within the
ﬁeld of biosensing. What NW arrays could add to this is the
option of intracellular sensors.
Any cellular event is related to the modulation of the intracel-
lular concentrations of cations and other messengers. There are
increasing applications in cell imaging using such signals as an
indicator of protein functionality (Lang et al., 2006). An exam-
ple is the monitoring of modulation of calcium concentrations
to report on the activity of G protein-coupled receptors, even if
the increase of calcium cations in the cell is the product of a
succession of reactions involving several proteins (Rudolf et al.,
2003). The advantage of this downstream monitoring is already
realized in drug discovery, with the development of assays in
living cells rather than on isolated proteins, in order to integrate
the biological complexity of cell signaling.
Current ﬂuorescence-based sensors rely on the loading of cells
with environment-sensitive ﬂuorescent dyes. Some technical lim-
itations regarding the efﬁciency and reproducibility of loading the
dyes in the cell have been partly solved using translocated par-
ticles grafted with well-deﬁned numbers of dyes (Wilson et al.,
2007). Arrays of NWs can be used similarly to those particles
because they can be functionalized with multiple compounds
(Liu, unpublished; Patolsky et al., 2006; Stern et al., 2007)
(Fig. 4). Moreover, as discussed earlier, the NWs can be made
from different materials and doped with other elements or coated
with protective or active layers; this opens up opportunities for
the design of sensors with novel intrinsic properties to be directly
exploited for cellular sensing.
The geometry of NWs and their immobilization on surfaces
present two additional advantages compared to existing sensors:
control of the number of sensors per cell and location of the sen-
sors in the cell (Fig. 4), allowing a three-dimensional mapping
of cellular events. This would especially be relevant within neu-
roscience for mapping signal propagation in a single nerve cell,
but also in neuronal networks (Namiki et al., 2007; Wilson et al.,
2005). The work of Hällström et al., indicates that even neuronal
axons could b penetrated by NWs, which makes it interesting to
investigate the potential of NW arrays for mapping signal prop-
agation in ﬁne networks of axons and dendrites.
Electrophysiology in a Cell Using Arrays of
Nanowires
In 2006, McKnight et al., developed an array of individually
contacted electrically active carbon nanoﬁbers (CNF) on a sili-
con surface. This publication makes it reasonable to start looking
into the application of NWs as nanoelectrodes in electrophysi-
ology measurements (Fig. 5). With this device McKnight et al.,
succeeded in getting electrical responses from oxidative events
occurring in intercellular regions of a neuronal culture that had
been cultured directly on the nanoﬁbers. The same type of array
Fig. 4. Present and future applications of NW arrays interfaced with liv-
ing cells: Biosensor. Cell on a NW array illustrating the potential as a
ﬂuorescence biosensor. NWs can be functionalized with environment-
sensitive ﬂuorophores (yellow, red, green) and provide spatially resolved
information both within a single cell and in networks of cells.
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Fig. 5. Present and future applications of NW arrays interfaced with liv-
ing cells: Electrophysiology. Cell on NW array illustrating the potential of
NWs as intra- and extracellular nanoelectrodes in electrophysiology. Each
NW can be electrically contacted through the surface (yellow). Changes
in whole-cell potential are measured as a change in potential with respect
to a standard-size extracellular counter electrode (yellow triangle). The
array enables single-cell measurements on multiple cells simultaneously,
representing future applications for HTS of drugs that target ion channels.
of CNFs has also been used for measuring electrophysiological
activity in rat neural tissue slices (Yu et al., 2007).
A widely used tool in neuroscience is the patch clamp tech-
nique, used for measuring the activity of ion channels in the cell
membrane. In traditional whole-cell patch clamp measurements
intracellular access is attained by rupturing the cell membrane
by means of applying suction pulses to a pipette attached to the
cell membrane. After the cell membrane is broken, the saline
solution in the pipette intermixes with the cytosol of the cell
causing a change in the balance of the cell’s intracellular solu-
tion. This change affects the function of ion channels and reduces
the lifetime of the cell.
Standard laboratory patch clamp techniques still rely on the
laborious use of a single glass patch pipette. This makes the
testing of drug candidates acting on ion channels a very time-
consuming and expensive process. An automated method for per-
forming high-quality patch clamp measurements is thus highly
attractive for the pharmaceutical industry (Dunlop et al., 2008). In
the last few years so-called planar chip-based patch clamp meth-
ods, suitable for high-throughput screening, have been developed
(Asmild et al., 2003; QPatch 16 by Sophion Bioscience A/S).
These systems typically consist of a surface having one or more
holes (oriﬁces) where cells are positioned by suction and electro-
physiological measurements are performed. Although the planar
patch clamp offers a less laborious operation than standard patch
clamp, it still necessitates the same harmful rupture of the cell
membrane.
The most appealing prospective of NW-electrodes would
be their application as less invasive intracellular electrodes.
If a high-resistance electrical seal can be obtained between
the NW electrode and the extracellular buffer solution, high-
quality measurements of the cell membrane potential is possi-
ble. Such a “built-in” electrode would facilitate high-quality ultra
high throughput (UHT) drug screening not possible with present
state-of-the-art technology.
On the other hand, NW-electrodes might also pose a potential
threat to the viability of the cells. Their electrochemical behavior
inside the cell has so far not been investigated and one could
imagine problems with, for example, gas generation at the elec-
trodes when current is drawn from such NWs.
NWs could also be used advantageously in another area of
electrophysiology; to replace “sharp glass electrodes.” Sharp
electrodes are used for monitoring the potential inside a cell. Due
to their small tip size (0.01–0.1 m) the electrode resistance is
often an order of magnitude higher (>100 M) than seen in
normal patch pipettes. (The Axon CNS Guide, 2006). This high
resistance causes a lot of electrical noise, which sets a limit to
the sensitivity of the measurement. NW electrodes could offer a
much lower electrode resistance and hence noise level, while at
the same time substantially prolonging the cell lifetime.
In addition to the expected less invasive nature of the NWs,
their small dimensions make it feasible to fabricate large arrays
of NW electrodes, which can be addressed individually (Fig. 5).
This would facilitate the incorporation of several electrodes in
one cell, which would provide valuable information with a spatial
resolution not possible by other means.
Furthermore, an array of NW electrodes could provide a
visionary platform for probing electrophysiological properties not
only of individual living cells, but also of networks of cells com-
municating; for example, neuronal networks. Understanding this
signalling process and the ﬂow of information between com-
plex networks of cells would provide new, basic information
crucial to areas like neuroscience, systems biology, and drug
development.
CONCLUSION
NW arrays appear to be promising tools for nanomedicine, with
a multitude of putative applications in drug delivery, diagnostics,
and high-throughput screening of new molecules. The potential
of arrays of NWs apply to a large range of cell types, with various
adhesion properties, suggesting that such arrays can be adapted
to a variety of cell cultures and tissues.
The ﬁrst set of applications concerns in vitro investigation
of cell cultures or isolated tissues for fundamental investiga-
tion of cellular signaling and cell/cell communication, but also
the design of novel high-throughput screening strategies for new
potentially therapeutic compounds or diagnostics on biopsies.
A second set of future applications concerns use of NW arrays
in human tissue for innovative therapies. The combination of the
properties of arrays of NWs with ﬁne surgery presents a promis-
ing potential for local treatments, including tumor cells. Such
applications will ﬁrst require overcoming some technical limita-
tions regarding the interface of cells with NWs, and a detailed
investigation of their short- and long-term toxicity.
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